No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
SMMT Summit Therapeutics
- 17.870
- -0.530-2.88%
Close Dec 20 16:00 ET
- 17.990
- +0.120+0.67%
Post 20:01 ET
13.18BMarket Cap-77.70P/E (TTM)
18.603High17.710Low7.10MVolume18.020Open18.400Pre Close127.54MTurnover6.18%Turnover RatioLossP/E (Static)737.45MShares33.89052wk High30.08P/B2.05BFloat Cap2.10052wk Low--Dividend TTM114.94MShs Float33.890Historical High--Div YieldTTM4.85%Amplitude0.660Historical Low17.965Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Why Did Summit Therapeutics Inc. (SMMT) Jump Yesterday?
Where Will Summit Therapeutics Be in 5 Years?
Summit Therapeutics Shares Are Trading Higher. The Stock May Be Moving in Sympathy With Neurocrine Biosciences Which Received FDA Approval for CRESNESSITY.
Watching Summit Therapeutics; Traders Circulate Newsletter Mention
How Is The Market Feeling About Summit Therapeutics?
Summit Therapeutics Initiated at Overweight by Wells Fargo
Heat List
US
Overall
Symbol
Price
% Chg
No Data